These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29378645)
41. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465 [TBL] [Abstract][Full Text] [Related]
42. Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel. Guzzi LM; Bergler T; Binnall B; Engelman DT; Forni L; Germain MJ; Gluck E; Göcze I; Joannidis M; Koyner JL; Reddy VS; Rimmelé T; Ronco C; Textoris J; Zarbock A; Kellum JA Crit Care; 2019 Jun; 23(1):225. PubMed ID: 31221200 [TBL] [Abstract][Full Text] [Related]
43. Urinary [TIMP-2]·[IGFBP7] - Novel Biomarkers to Predict Acute Kidney Injury. Kimmel M; Shi J; Wasser C; Biegger D; Alscher MD; Schanz MB Am J Nephrol; 2016; 43(5):375-82. PubMed ID: 27174659 [TBL] [Abstract][Full Text] [Related]
44. Cardiac biomarkers are associated with maximum stage of acute kidney injury in critically ill patients: a prospective analysis. Haines R; Crichton S; Wilson J; Treacher D; Ostermann M Crit Care; 2017 Apr; 21(1):88. PubMed ID: 28399905 [TBL] [Abstract][Full Text] [Related]
45. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA; J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301 [TBL] [Abstract][Full Text] [Related]
46. Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients. Yegenaga I; Kamis F; Baydemir C; Erdem E; Celebi K; Eren N; Baykara N Ann Clin Biochem; 2018 Mar; 55(2):190-197. PubMed ID: 28142264 [TBL] [Abstract][Full Text] [Related]
47. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Kellum JA; Chawla LS Nephrol Dial Transplant; 2016 Jan; 31(1):16-22. PubMed ID: 26044835 [TBL] [Abstract][Full Text] [Related]
48. Limits of neutrophil gelatinase-associated lipocalin at intensive care unit admission for prediction of acute kidney injury. Darmon M; Gonzalez F; Vincent F Am J Respir Crit Care Med; 2011 Jul; 184(1):142-3; author reply 143. PubMed ID: 21737594 [No Abstract] [Full Text] [Related]
49. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. Meersch M; Schmidt C; Van Aken H; Rossaint J; Görlich D; Stege D; Malec E; Januszewska K; Zarbock A PLoS One; 2014; 9(10):e110865. PubMed ID: 25343505 [TBL] [Abstract][Full Text] [Related]
50. Repair or progression after AKI: a role for biomarkers? Srisawat N; Murugan R; Kellum JA Nephron Clin Pract; 2014; 127(1-4):185-9. PubMed ID: 25343847 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of biomarkers of cell cycle arrest and inflammation in prediction of dialysis or recovery after kidney transplantation. Pianta TJ; Peake PW; Pickering JW; Kelleher M; Buckley NA; Endre ZH Transpl Int; 2015 Dec; 28(12):1392-404. PubMed ID: 26174580 [TBL] [Abstract][Full Text] [Related]
53. Urinary [TIMP-2]·[IGFBP7]-guided implementation of the KDIGO bundle to prevent acute kidney injury: a meta-analysis. Li Z; Tie H; Shi R; Rossaint J; Zarbock A Br J Anaesth; 2022 Jan; 128(1):e24-e26. PubMed ID: 34794767 [No Abstract] [Full Text] [Related]
54. Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study. Deng Y; Chi R; Chen S; Ye H; Yuan J; Wang L; Zhai Y; Gao L; Zhang D; Hu L; Lv B; Long Y; Sun C; Yang X; Zou X; Chen C Crit Care; 2017 Mar; 21(1):46. PubMed ID: 28264714 [TBL] [Abstract][Full Text] [Related]
55. Biomarker discovery in mass spectrometry-based urinary proteomics. Thomas S; Hao L; Ricke WA; Li L Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953 [TBL] [Abstract][Full Text] [Related]
56. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin. Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902 [TBL] [Abstract][Full Text] [Related]
57. Bench to bedside: the next steps for biomarkers in acute kidney injury. Pickering JW; Endre ZH Am J Physiol Renal Physiol; 2016 Oct; 311(4):F717-F721. PubMed ID: 27465990 [TBL] [Abstract][Full Text] [Related]
58. Rationalizing the use of NGAL in the intensive care unit. Glassford NJ; Eastwood GM; Young H; Peck L; Schneider AG; Bellomo R Am J Respir Crit Care Med; 2011 Jul; 184(1):142; author reply 143. PubMed ID: 21737595 [No Abstract] [Full Text] [Related]
59. The intensive care medicine agenda on acute kidney injury. Pickkers P; Ostermann M; Joannidis M; Zarbock A; Hoste E; Bellomo R; Prowle J; Darmon M; Bonventre JV; Forni L; Bagshaw SM; Schetz M Intensive Care Med; 2017 Sep; 43(9):1198-1209. PubMed ID: 28138736 [TBL] [Abstract][Full Text] [Related]
60. Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury. Kane-Gill SL; Smithburger PL; Kashani K; Kellum JA; Frazee E Drug Saf; 2017 Nov; 40(11):1049-1074. PubMed ID: 28674842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]